← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2016Last known activity
May 14, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 13 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06968962CollaboratorN/AMay 14, 2025
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT06452147CollaboratorN/AJun 19, 2024
- NCT06221462Lead sponsorPhase 2Feb 1, 2024
- NCT06221462OfficialPhase 2Feb 1, 2024
- NCT06020066Overall official - principal investigatorPhase 2Aug 10, 2023
- NCT06020066OfficialPhase 2Aug 10, 2023
- NCT05728645CollaboratorN/AJul 12, 2023
- NCT05231694CollaboratorPhase 4Apr 1, 2022
- NCT04694248CollaboratorN/AJun 1, 2021
- NCT05531344CollaboratorPhase 2/Phase 3Aug 20, 2020
- NCT04519905CollaboratorN/AJan 6, 2020
- NCT03792542CollaboratorPhase 2Jan 31, 2019
- NCT03726736CollaboratorPhase 1/Phase 2Dec 21, 2018
- NCT02702323CollaboratorPhase 2/Phase 3Mar 1, 2016
Details
- Last known activity
- May 14, 2025